Simply Wall St.48d agoneutral
3 Defensive Dividend Stocks For Steady Income as Fed Pressure BuildsNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.54d agobearish
Abbott Laboratories (ABT) Agrees To $385 Million Infant Formula Recall SettlementThe Wall Street Journal55d agoneutral
Abbott Agrees to $385 Million Settlement in Baby Formula Case24/7 Wall St.69d agoneutral
Two Recessions Couldn’t Stop These 4 Healthcare Stocks From Raising DividendsInsider Monkey93d agoneutral
What Makes Abbott Laboratories (ABT) a Compelling Investment Opportunity with Reliable GrowthSimply Wall St.114d agoneutral
US Stock Market Today: S&P 500 Futures Dip On Tariff And Energy Cost WorriesThe Wall Street Journal115d agoneutral
Netflix Earnings, Consumer Sentiment: What to Watch the Rest of the WeekInsider Monkey134d agobearish
Abbott Laboratories (ABT) must face a Lawsuit over PediaSure, Statements about Children’s Growth24/7 Wall St.137d agobullish
Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to BuyInsider Monkey138d agoneutral
Jim Cramer on Boston Scientific: “This Whole Cohort Is Just Too Hard to Own”Insider Monkey170d agoneutral
Abbott Laboratories (ABT) Slid Due To Its Nutrition Segment’s Sensitivity to Consumer Spending Momentum